Compugen (CGEN) Long-Term Investments (2009 - 2015)
Compugen (CGEN) posted quarterly Long-Term Investments of $3.7 million for Q1 2026, up 29.86% year-over-year from $2.9 million in Q1 2025, and up 2.31% on a QoQ basis from $3.6 million in Q4 2025.
Analysis
Compugen (CGEN) Long-Term Investments (2009 - 2015) Analysis & Trends
Compugen has reported Long-Term Investments for 18 years, with the latest figure at $3.7 million in Q1 2026.
- Long-Term Investments for Q1 2026 came in at $3.7 million, up 29.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 29.86% YoY), and the FY2025 annual result was $3.6 million, up 18.59% from the prior year.
- Long-Term Investments rose to $3.7 million in Q1 2026, from $3.6 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $3.7 million in Q1 2026 and troughed at $2.8 million in Q1 2023.
- A 5-year average of $3.1 million and a median of $3.0 million in 2024 frame the typical range for Long-Term Investments.
- The widest annual swing landed in 2023, when Long-Term Investments decreased 11.19%; it then rose 29.86% in 2026.
- A 5-year view of Long-Term Investments shows it stood at $2.8 million in 2022, then advanced by 6.55% to $3.0 million in 2023, then advanced by 3.19% to $3.1 million in 2024, then rose by 18.59% to $3.6 million in 2025, then advanced by 2.31% to $3.7 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $3.7 million in Q1 2026, $3.6 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Compugen | 241.50 Mn | 155.89 Mn | -92,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 15.01 Mn |
| Mar 31, 2015 | 2.01 Mn |
| Dec 31, 2014 | 35.03 Mn |
| Sep 30, 2014 | 2.08 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Mar 31, 2014 | 2.16 Mn |
| Dec 31, 2013 | 2.13 Mn |
| Sep 30, 2013 | 2.01 Mn |
| Jun 30, 2013 | 1.92 Mn |
| Mar 31, 2013 | 1.88 Mn |
| Dec 31, 2012 | 1.73 Mn |
| Sep 30, 2012 | 5.89 Mn |
| Jun 30, 2012 | 6.26 Mn |
| Mar 31, 2012 | 6.27 Mn |
| Dec 31, 2011 | 5.58 Mn |
| Sep 30, 2011 | 5.69 Mn |
| Jun 30, 2011 | 6.57 Mn |
| Mar 31, 2011 | 7.40 Mn |
| Dec 31, 2010 | 7.80 Mn |
| Sep 30, 2010 | 6.76 Mn |